Step Therapy Requirements Decoded: Why Insurers Make You Fail First

What Step Therapy Actually Means for Your GLP-1 Prescription

Step therapy — sometimes called "fail-first" — is an insurance utilization management strategy that requires you to try less expensive treatments before the insurer will approve coverage for a more expensive one. For GLP-1 medications, this typically means documenting that behavioral interventions (diet, exercise, counseling) or less expensive medications (orlistat, phentermine) were attempted and didn't achieve the desired clinical outcome.

The insurer's logic: GLP-1 medications cost $900-1,300+ per month at list price. If a $30/month generic medication or a behavioral program achieves the same result, the insurer wants you to try that first. In practice, the evidence strongly supports GLP-1 superiority over older interventions — but insurance formulary design often lags behind clinical evidence by years.

Step therapy doesn't mean you can never get a GLP-1. It means you need to document the journey of trying other approaches first. Understanding what counts as a "step" and what counts as "failure" puts you in control of the process.

Common Steps Insurers Require (and How to Clear Them)

Most insurers require 1-3 of the following steps before approving GLP-1 coverage for weight management:

Step 1: Documented Lifestyle Modification (3-6 Months)

This is the most common requirement. You need evidence that you participated in a structured diet and exercise program. What counts: nutritionist visits, registered dietitian consultations, medically supervised weight management programs, or documented participation in programs like the Diabetes Prevention Program (DPP). What usually doesn't count: a gym membership or self-directed dieting without clinical documentation.

Step 2: Prior Medication Trial

Some insurers require a trial of an older, less expensive weight loss medication. Orlistat (Xenical/Alli) is the most commonly required step. Some plans also accept documented trials of phentermine/topiramate (Qsymia) or naltrexone/bupropion (Contrave). A trial typically needs to last 3-6 months with documented insufficient weight loss (usually less than 5% body weight reduction).

Step 3: Specialist Referral

A smaller number of plans require evaluation by an endocrinologist or bariatric medicine specialist before approving GLP-1 coverage. This step is more common in higher-cost plans and government employee plans.

What Counts as 'Failure' to Clear a Step

The definition of "failure" varies by insurer, but generally means one of the following:

Insufficient weight loss: Less than 5% of body weight lost after 3-6 months of documented effort. This is the most common failure criterion.

Intolerable side effects: If a required medication (orlistat, phentermine) caused side effects that made continued use medically inappropriate, that counts as a clinical failure of the step.

Medical contraindication: If a required medication is contraindicated for you — for example, phentermine is contraindicated in patients with uncontrolled hypertension or a history of cardiovascular events — you can request a step therapy exception, bypassing that requirement entirely.

Clinical deterioration: If your weight-related comorbidities worsened during the step therapy period (A1C increased, blood pressure rose, sleep apnea severity increased), that strengthens the case for moving to a GLP-1.

Document everything. Every nutritionist visit note, every weigh-in, every medication trial and its outcome, every lab result. Your prescriber will compile this documentation into the prior authorization request.

Appealing a Step Therapy Requirement

You have the right to appeal step therapy requirements, and appeals succeed more often than patients expect — especially when the documentation is strong.

Exception requests: Most insurers have a formal process for requesting step therapy exceptions. Your prescriber submits a letter explaining why GLP-1 treatment is medically necessary without completing the required steps. Valid reasons include: medical contraindication to the step medication, clinical urgency (rapidly worsening comorbidities), or prior completion of similar steps under a different insurance plan.

Peer-to-peer review: If the written exception is denied, your prescriber can request a peer-to-peer review — a phone call with the insurer's medical director. This is often the most effective step in the appeal process because it allows your doctor to make a clinical argument directly to another physician, rather than having a claims processor evaluate written documentation.

If the appeal fails, you're back to the options: complete the step therapy as documented, or explore cash-pay alternatives while the process plays out.